Drawing for MYREXIS PHARMACEUTICALS

USPTO serial 77945131

MYREXIS PHARMACEUTICALS

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
GAST, PAUL
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with MYREXIS PHARMACEUTICALS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Michael E. Mangelson

MICHAEL E. MANGELSON STOEL RIVES LLP201 S MAIN STSALT LAKE CITY, UT 84111-2215UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations and substances for the treatment of viral, bacterial, infectious, genetic, auditory, hematological, reproductive, lymphatic, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; pharmaceutical preparations for use in effecting analgesia and in pain management; pharmaceutical products for the prevention and treatment of cancerACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Oct 24, 2011MAB6ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Oct 24, 2011ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Aug 31, 2011ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Mar 23, 2011EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Mar 22, 2011EX1GSOU EXTENSION 1 GRANTED—
Mar 22, 2011AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Mar 3, 2011EXT1SOU EXTENSION 1 FILED—
Mar 3, 2011MAILPAPER RECEIVED—
Sep 21, 2010NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jul 27, 2010NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jul 27, 2010PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jun 21, 2010PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Jun 21, 2010ALIEASSIGNED TO LIE—
Jun 4, 2010CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jun 4, 2010XAECEXAMINER'S AMENDMENT ENTERED—
Jun 4, 2010GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Jun 4, 2010GNEAEXAMINERS AMENDMENT E-MAILED—
Jun 4, 2010CNEAEXAMINERS AMENDMENT -WRITTEN—
Jun 1, 2010DOCKASSIGNED TO EXAMINER—
Mar 3, 2010NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Mar 1, 2010NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance